Indaptus Therapeutics prices USD 24 million private placement of 20,338,974 shares
INDP•Private placement terms
Indaptus Therapeutics entered a stock purchase agreement on Sept. 8, 2026 for a private placement of 20,338,974 shares.
Gross proceeds are expected to be about $24 million, before expenses.
Pricing was set at the Nasdaq Minimum Price, as defined in the agreement, plus USD 0.015 per share.
Use of proceeds and offering details
Net proceeds are earmarked for working capital, research and development, and general corporate purposes.
The shares were sold in an unregistered offering under Section 4(a)(2) and/or Regulation S, and are subject to transfer restrictions.
